Kathleen M. Hunter-Gregory
Treasurer at Sertoli Technologies LLC
Profile
Ms. Kathleen M.
Hunter-Gregory is Controller at RCT BioVentures and Treasurer at Sertoli Technologies, Inc.
Ms. Hunter-Gregory joined Research Corporation Technologies in 1992 and has served in a variety of different roles.
She received her BS from the University of Arizona and is a Certified Public Accountant.
Kathleen M. Hunter-Gregory active positions
| Companies | Position | Start |
|---|---|---|
Sertoli Technologies LLC
 Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Treasurer | 14/02/2010 |
Former positions of Kathleen M. Hunter-Gregory
| Companies | Position | End |
|---|---|---|
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Comptroller/Controller/Auditor | - |
Training of Kathleen M. Hunter-Gregory
| University of Arizona | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
Sertoli Technologies LLC
Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Health Services |
- Stock Market
- Insiders
- Kathleen M. Hunter-Gregory
